Less non-major bleeding with apixaban versus warfarin among patients with atrial fibrillation: insights from the ARISTOTLE trial

被引：0
|
作者：
Bahit, M. C. [1 ]
Lopes, R. D. [2 ]
Wojdyla, D. M. [2 ]
Held, C. [3 ]
Hanna, M. [4 ]
Vinereanu, D. [5 ]
Goto, S. [6 ]
Alexander, J. H. [2 ]
Wallentin, L. [3 ]
Granger, C. B. [2 ]
机构：
[1] INECO Neurociencias, Rosario, Santa Fe, Argentina
[2] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27706 USA
[3] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden
[4] Bristol Myers Squibb Co, Princeton, NJ USA
[5] Univ Med & Pharm Carol Davila, Bucharest, Romania
[6] Tokai Univ, Sch Med, Isehara, Kanagawa 25911, Japan
来源：
EUROPEAN HEART JOURNAL | 2015年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1973
引用
收藏
页码：338 / 339
页数：2
相关论文
共 50 条
  • [1] Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation
    Bahit, M. Cecilia
    Lopes, Renato D.
    Wojdyla, Daniel M.
    Held, Claes
    Hanna, Michael
    Vinereanu, Dragos
    Hylek, Elaine M.
    Verheugt, Freek
    Goto, Shinya
    Alexander, John H.
    Wallentin, Lars
    Granger, Christopher B.
    [J]. HEART, 2017, 103 (08) : 623 - 628
  • [2] History of Bleeding and Outcomes with Apixaban versus Warfarin in Patients with Atrial Fibrillation in the ARISTOTLE Trial
    De Caterina, Raffaele
    Andersson, Ulrika
    Alexander, John H.
    Bahit, M. Cecilia
    Commerford, Patrick J.
    Goto, Shinya
    Granger, Christopher B.
    Hanna, Michael
    Held, Claes
    Hohnloser, Stefan H.
    Hylek, Elaine M.
    Lanas, Fernando
    Lopes, Renato D.
    Lopez-Sendon, Jose L.
    Wallentin, Lars
    [J]. CIRCULATION, 2014, 130
  • [3] APIXABAN VERSUS WARFARIN FOR PATIENTS WITH RECENT ONSET ATRIAL FIBRILLATION: INSIGHTS FROM THE ARISTOTLE TRIAL
    Guimaraes, Patricia
    Alexander, John
    Wojdyla, Daniel
    Thomas, Laine
    Alings, Marco
    Flaker, Greg
    Al-Khatib, Sana
    Hanna, Michael
    Wallentin, Lars
    Granger, Christopher
    Lopes, Renato
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 691 - 691
  • [4] Apixaban versus warfarin in Patients with Atrial Fibrillation in relation to Prior Warfarin Use: Insights from the ARISTOTLE trial
    Garcia, David A.
    Alexander, John H.
    Lopes, Renato D.
    Thomas, Laine
    Yang, Hongqiu
    Ansell, Iack
    Commerford, Patrick
    Flaker, Greg
    Lanas, Fernando
    Mohan, Puneet
    Vinereanu, Dragos
    Xavier, Denis
    Granger, Christopher
    Wallentin, Lars
    [J]. CIRCULATION, 2012, 126 (21)
  • [5] Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial
    Held, Claes
    Hylek, Elaine M.
    Alexander, John H.
    Hanna, Michael
    Lopes, Renato D.
    Wojdyla, Daniel M.
    Thomas, Laine
    Al-Khalidi, Hussein
    Alings, Marco
    Xavier, Dennis
    Ansell, Jack
    Goto, Shinya
    Ruzyllo, Witold
    Rosenqvist, Marten
    Verheugt, Freek W. A.
    Zhu, Jun
    Granger, Christopher B.
    Wallentin, Lars
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 (20) : 1264 - 1272
  • [6] Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Left Ventricular Hypertrophy Insights From the ARISTOTLE Trial
    Al-Khatib, Sana M.
    Mulder, Hillary
    Wojdyla, Daniel
    Lopes, Renato D.
    Wallentin, Lars
    Alexander, John H.
    Hijazi, Ziad
    Goto, Shinya
    Granger, Christopher B.
    [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2021, 14 (03): : 359 - 361
  • [7] Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
    Garcia, David A.
    Fisher, Deborah A.
    Mulder, Hillary
    Wruck, Lisa
    De Caterina, Raffele
    Halvorsen, Sigrun
    Granger, Christopher B.
    Held, Claes
    Wallentin, Lars
    Alexander, John H.
    Lopes, Renato D.
    [J]. AMERICAN HEART JOURNAL, 2020, 221 : 1 - 8
  • [8] Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial
    Alexander, Karen P.
    Brouwer, Marc A.
    Mulder, Hillary
    Vinereanu, Dragos
    Lopes, Renato D.
    Proietti, Marco
    Al-Khatib, Sana M.
    Hijazi, Ziad
    Halvorsen, Sigrun
    Hylek, Elaine M.
    Verheugt, Freek W. A.
    Alexander, John H.
    Wallentin, Lars
    Granger, Christopher B.
    [J]. AMERICAN HEART JOURNAL, 2019, 208 : 123 - 131
  • [9] Efficacy and safety of apixaban versus warfarin in patients with atrial fibrillation and active cancer: insights from the ARISTOTLE trial
    Melloni, C.
    Dunning, A.
    Granger, C. B.
    Thomas, L.
    Khouri, M.
    Garcia, D. A.
    Hylek, E. M.
    Wallentin, L.
    Gersh, B. J.
    Douglas, P. S.
    Alexander, J. H.
    Lopes, R. D.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 234 - 234
  • [10] Efficacy and Safety of Apixaban Versus Warfarin in Patients with Atrial Fibrillation and a History of Cancer: Insights from the ARISTOTLE Trial
    Melloni, Chiara
    Dunning, Allison
    Granger, Christopher B.
    Thomas, Laine
    Khouri, Michel G.
    Garcia, David A.
    Hylek, Elaine M.
    Hanna, Michael
    Wallentin, Lars
    Gersh, Bernard J.
    Douglas, Pamela S.
    Alexander, John H.
    Lopes, Renato D.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2017, 130 (12): : 1440 - +
12345